Cervos Medical products

CF-G5 A volume of 5cc of granules based on the patented highly cross-linked carbohydrate graft that has been cleared through the FDA 510(k) process (K170165).  The fetus develops tissues using a carbohydrate structure through glycosylation. This process continues in adulthood where leukocytes use the L-selectin on their surface to attach to damaged blood vessels which are coated with carbohydrate molecules.  

CF-G10 A volume of 10cc of granules based on the patented highly cross-linked carbohydrate graft that has been cleared through the FDA 510(k) process (K170165).  The fetus develops tissues using a carbohydrate structure through glycosylation. This process continues in adulthood where leukocytes use the L-selectin on their surface to attach to damaged blood vessels which are coated with carbohydrate molecules.